The Effect of Propofol on Dexamethasone-induced Perineal Pruritus

Status Completed

Clinical Trial Summary

patients may appear serious perineal itching, after injection of dexamethasone sodium phosphate injection its incidence is about 25% ~ 100%, and the incidence of the discomfort in females was much higher than that of the maleTo investigate the effect of propofol pretreatment on perineal pruritus induced by dexamethasone sodium phosphate injection and explore the possible machanisms.

Clinical Trial Description

40 patients scheduled for selective surgery,aged 18-65years,ASA physical status I~II,BMI 18~30kg/m2 were selected in this study.The patients were equally randomized into two groups: propofol (P) group and normal saline (N) group, 20 cases in each group. Before anesthesia induction, M group received intravenous injection of 0.3mg/kg propofol , while N group received corresponding intravenous normal saline of the same volume. After 1 min, both groups received intravenous injection of dexamethasone sodium phosphate injection of 10mg. The anesthesiologist assessed perineal irritation in both groups and recorded Ramsay scores,the number of cases, visual analogue scale(VAS) scores ,duration of itching and observed the occurrence of adverse reactions such as dizziness, hypotension and respiratory depression in the two groups. ;

Study Design

Related Conditions & MeSH terms

Pruritus

Clinical Trial Details

NCT number	NCT04337073
Study type	Interventional
Source	Yangzhou University
Contact
Status	Completed
Phase	Early Phase 1
Start date	September 1, 2020
Completion date	November 30, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05038982` - Efficacy of Abrocitinib for Reducing Pruritus in Adults With Prurigo Nodularis and Chronic Pruritus of Unknown Origin	Phase 2
Completed	`NCT04510090` - Evaluate the Safety, Tolerability, and PK of EP547 in Healthy Subjects and Subjects With Cholestatic or Uremic Pruritus	Phase 1
Completed	`NCT02143973` - Open Label Extension Study of Nalbuphine HCl ER in Hemodialysis Patients With Uremic Pruritus	Phase 2/Phase 3
Terminated	`NCT01825655` - Study of Using Long Acting Antihistamine to Treat Opioid Induced Itching	Phase 4
Completed	`NCT01236859` - Gabapentin for Prophylaxis Intrathecal Morphine-Induced Pruritus	N/A
Completed	`NCT00782054` - Evaluation of Post Burn Rehabilitation Population for Itch Control	Phase 4
Completed	`NCT04999787` - A Clinical Trial Evaluating the Efficacy, Safety, and Pharmacokinetics of HSK21542 Injection in Liver Disease Subjects With Pruritus	Phase 2
Recruiting	`NCT04256759` - Dupilumab for the Treatment of Moderate to Severe Chronic Hepatic Pruritus	Phase 2
Completed	`NCT04415034` - Scalp Pruritus Measurement Using Visual Analog Scale and 5-d Itch Scale in Children With Pediculosis Capitis
Active, not recruiting	`NCT05525520` - Study to Evaluate EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing Cholangitis	Phase 2
Recruiting	`NCT03340155` - Mechanisms of Action of Photo(Chemo)Therapy in Skin Diseases	N/A
Completed	`NCT04399525` - Influence of H1-antihistamines on the Dermal Blood Flow Response to Histamine, Cinnamaldehyde and Capsaicin.	N/A
Recruiting	`NCT02432508` - Efficacy of Laser Acupuncture on Pruritus in Patients With Chronic Kidney Disease Undergoing Hemodialysis	N/A
Completed	`NCT02653703` - L-menthol as a Topical Counter-irritant to TRPA1-induced Neurogenic Inflammation and Pain	N/A
Completed	`NCT01963793` - Topical Aprepitant in Prurigo Patients	Phase 2
Completed	`NCT01232985` - Efficacy and Tolerability Study of Device, RD047-26 for the Treatment of Mild to Moderate Atopic Dermatitis in Adults	Phase 2
Not yet recruiting	`NCT00577967` - Gabapentin - A Solution to Uremic Pruritus?	N/A
Recruiting	`NCT06120907` - Swiss Itch Registry
Recruiting	`NCT04589429` - Adding Nalbuphine for Control of Intrathecal Morphine Pruritus	Phase 2
Completed	`NCT03322137` - Safety, Efficacy, and Tolerability of SNA-120 in Subjects With Pruritus Associated With Psoriasis Vulgaris	Phase 2